Compare WSO & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WSO | HOLX |
|---|---|---|
| Founded | 1945 | 1985 |
| Country | United States | United States |
| Employees | 7050 | N/A |
| Industry | Industrial Machinery/Components | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 16.9B |
| IPO Year | N/A | 1995 |
| Metric | WSO | HOLX |
|---|---|---|
| Price | $422.47 | $76.02 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 13 |
| Target Price | ★ $410.00 | $77.89 |
| AVG Volume (30 Days) | 484.7K | ★ 9.6M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.17% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $3.12 | $4.74 |
| Revenue Next Year | $5.10 | $5.03 |
| P/E Ratio | ★ $34.24 | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $323.05 | $51.90 |
| 52 Week High | $509.71 | $76.07 |
| Indicator | WSO | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 66.34 | 69.09 |
| Support Level | $418.31 | $75.10 |
| Resistance Level | $427.50 | N/A |
| Average True Range (ATR) | 14.04 | 0.19 |
| MACD | 6.32 | 0.03 |
| Stochastic Oscillator | 95.70 | 95.19 |
Watsco is the largest HVAC and refrigeration products distributor in North America with approximately 13% market share. The company primarily operates in the United States (90% of revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada, Latin America, and the Caribbean. The company's customer base comprises more than 120,000 dealers and contractors serving the replacement and new-construction HVAC/R markets for residential and light-commercial applications. As much as 20% of residential HVAC units are distributed through Watsco in any given year. Revenue is approximately 75%-80% residential HVAC and 20%-25% commercial, with relatively small exposure to more complex "applied" solutions.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.